Диссертация (1141239), страница 26
Текст из файла (страница 26)
д-ра мед.наук., М., 1973.5.Черноусов А.Ф., Ручкин Д.В., Семенов А.Ю. Радикальное хирурги-ческое лечение пищевода Барретта // Хирургия. - 2001. - №1. - С. 20-32.6.Черноусов А.Ф., Сильвестров B.C., Курбанов Ф.С. Пластика пищеводапри раке и доброкачественных стриктурах. — М.: Медицина, 1990. - 144 с.7.Черноусов А.Ф., Т.В. Хоробрых, Ф.П. Ветшев Хирургическое лечениебольных с приобретенным коротким пищеводом, Вестник Национальногомедико-хирургического Центра им.
Н.И. Пирогова. 2011, №1, С. 28-35.8.Abbas AE, Deschamps C, Cassivi SD, et al. Barrett's esophagus: the role oflaparoscopic fundoplication. Ann Thorac Surg 2004;77:393-396.9.Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsydetects Barrett's dysplasia in more patients than nonsystematic biopsy. Am JGastroenterol2008; 103: 850-855.10.Abrams JA, Fields S, Lightdale CJ, Neugut Al. Racial and ethnic disparitiesin the prevalence of Barrett's esophagus among patients who undergo upperendoscopy.
Clin Gastroenterol Hepatol 2008;6:30-34.11.Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S, et al.Comparative genomic analysis of esophageal adenocarcinoma and squamous cellcarcinoma. Cancer Discov 2012;2:899–905.12.Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, etal.Tumor cells circulate in the peripheral blood of all major carcinomas but not in157healthy subjects or patients with nonmalignant diseases. Clin Cancer Res2004;10:6897–904.13.Allison P.R., Johnstone A.S.The oesophagus lined with gastric mucousmembrane. Thorax.1953.14.Anaparthy R, Gaddam S, Kanakadandi V, et al.
Association between lengthof Barrett's oesophagus and risk of high-grade dysplasia or adenocarcinoma inpatients without dysplasia. Clin Gastroenterol Hepatol 2013;11:1430e6.15.Andrici J, Cox MR, Eslick GD. Cigarette smoking and the risk of Barrett‘sesophagus:asystematicreviewandmeta-analysis. JGastroenterolHepatol. 2013;28:1258–1273.16.Ashraf A. Mohamed, Khaled M.
Mahran, Mohamed M. Zaazou Impact ofLaparoscopic Nissen Fundoplication on Non-complicated Barrett‘s EsophagusSaudi J Gastroenterol. 2011 May-Jun; 17(3): 185–188.17.Attwood SE, Lundell L, Hatlebakk JG, etal. Medical or surgicalmanagement of GERD patients with Barrett's esophagus: the LOTUS trial 3-yearexperience. J Gastrointest Surg 2008; 12: 1646-1654.18.Barrett N.R. Chronic pepticulcer of the oesophagus and ―oesophagitis‖BrJSurg. 1950.19.Beardsmore D.M., Pring C.M., Clark G.W.B.
Are short segments of in-testinal metaplasia at the gastroesophageal junction strongly associated with refluxesophagitis? Barrett's Esophagus. 250 questions - 250 answers. R. Giuli, et al.(eds.) John Libbey Eurotext // Paris. - 2003. - P. 147-149.20.Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression inBarrett's oesophagus patients: results from a large population-based study J NatlCancer Inst 011;103:1049e57.21.BiomarkersDefinitionsWorkingG.Biomarkersandsurrogateendpoints:preferred definitions and conceptual framework. Clin Pharmacol Ther2001;69:89–95.22.Borrie J, Goldwater L.
Columnar cell-lined esophagus: assessment ofetiology and treatment: a 22 year experience. JThoracCardiovascSurg. 1976.15823.Bosher L.H., Taylor F.H. Heterotopic gastric mucosa in the esophagus withulceration and stricture formation. JThoracSurg. 1951.24.Briel JW, Tamhankar AP, Hagen JA, et al. Prevalence and risk factors forischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versuscolon interposition.
J Am Coll Surg. 2004;198:536 –541.25.Burgess J.N., Payne W.S., Andersen H.A., Weiland L.H., Carlson H.C.Barrett esophagus: the columnar-epithelial-lined lower esophagus. Mayo Clin.Proc. 1971.26.Cameron A.J. The Epidemiology of Barrett's Esophagus and Adenocar-cinoma // Pract. Gastroenterology. - 1995. - Vol. 19.
- N 6. - P. 24B-24F.27.Cameron A.J., Souto E.O., Smyrk T.C. Small adenocarcinomas of theesophagogastric junction: association with intestinal metaplasia and dysplasia //Am. J. Gastroenterol. - 2002. - Vol. 97. - N 6. - P. 1375-1380.28.Campos G.M., DeMeester S.R., Peters J.H. et al. Predictive factors of Barrettesophagus: multivariate analysis of 502 patients with gastroesophageal refluxdisease //Arch. Surg. -2001. -Vol.
136.-N11.-P. 1267-1273.29.Casson AG, Evans SC, Gillis A, Porter GA, Veugelers P, Darnton SJ, et al.Clinical implications of p53 tumor suppressor gene mutation and proteinexpression in esophageal adenocarcinomas: results of a ten-year prospective study.J Thorac Cardiovasc Surg 2003;125:1121–31.30.Chandrasoma P.T., Der R., Ma Y., Peters J., Demeester T.
Histologicclassification of patients based on mapping biopsies of the gastroesophagealjunction. Am J. Surg. Pathol. 2003; 27(7): 929-36.31.Chang EY, Morris CD, Seltman AK, et al. The effect of antireflux surgeryon esophageal carcinogenesis in patients with barrett oesophagus: a systematicreview. Ann Surg 2007;246:11e21.32.Chen H., Y. Fang,W. Tevebaugh et al., Molecular mechanisms of Barrett‘sesophagus,‖ Digestive Diseases and Sciences, vol.
56, no. 12, pp. 3405–3420,2011.15933.Clґement G., R. Braunschweig, N. Pasquier, F. T. Bosman, and J. Benhattar,―Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguishBarrett‘s oesophagus patients at risk for malignant transformation,‖ Journal ofPathology, vol. 208, no.
1, pp. 100–107, 2006.34.Collard J.M. High-grade dysplasia in Barrett's esophagus. The case foresophagectomy // Chest. Surg. Clin. N. Am. - 2002. - Vol. 12. - N 1. - P. 77-92.35.Conio M., Filiberti R., Blanchi S., et al. Gruppo Operativo per lo Studiodelle Precancerosi Esofagee (GOSPE). Risk factors for Barrett's esophagus: a casecontrol study // Int. J. Cancer. - 2002. - Vol. 97. -N 2. - P. 225-229.36.Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body massindex as risk factors for Barrett's esophagus.
Gastroenterology 2007; 133:34-4137.Coupland V. H., W. Allum, J. M. Blazeby et al., ―Incidence and survival ofoesophageal and gastric cancer in England between 1998 and 2007, a populationbased study,‖ BMC Cancer, vol. 12, article 11, 2012.38.Csendes А. Results of antireflux surgery in patients with Barrett'sesophagus, European Surgery August 2008, Volume 40, Issue 4, pp 154-164.39.DeMeester S.R., Bremner C.G., Chandrasoma P.T., DeMeester T.R.Barrett‗s esophagus can and does regress after antireflux surgery: a study ofprevalence and predictive features. J Am Coll Surg. 2003.40.DeMeester SR, Campos GM, DeMeester TR, et al. The impact of anantireflux procedure on intestinal metaplasia of the cardia.
Ann Surg1998;228:547e56.41.DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasiaof the oesophagus:fifty years of controversy. Ann Surg 2000;231:303e21.42.DeMeester Steven R., MD, Professor of Surgery Barrett's oesophagus:Treatment with surgery Best Practice & Research Clinical Gastroenterology 29(2015) 211e217.43.DeMeester T.R. Surgery for Esophageal Cancer: State of the Art and FuturePerspectives // Eur. Surg. - 2002. - Vol. 34 - N.
1 - P. 5-8.16044.Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW.The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett‘soesophagus: a meta-analysis. Gut.2012;61:970–976.45.Devriese LA, Voest EE, Beijnen JH, Schellens JH.
Circulating tumor cellsas pharmacodynamic biomarker in early clinical oncological trials. Cancer TreatRev 2011;37:579–89.46.Dumot JA, Vargo JJ II, Falk GW, et al. An open-label, prospective trial ofcryospray ablation for Barrett's esophagus high-grade dysplasia and earlyesophageal cancer in high-risk patients. Gastrointest Endosc. 2009; 70:635–644.47.Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M,Muller H, Seitz G, Stolte M.
Endoscopic mucosal resection of early cancer andhigh-grade dysplasia in Barrett's esophagus. // Gastroenterology. 2000 Apr;l18(4):670-7.48.Fang D., K. M. Das, W. Cao et al., ―Barrett‘s esophagus: progression toadenocarcinoma and markers,‖ Annals of theNew York Academy of Sciences, vol.1232, pp. 210–229, 2011.49.Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities asmarker of risk for progression of Barrett's esophagus to adenocarcinoma: imagecytometric DNA analysis in formalin-fixed tissues.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
